Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers (Q46765690)

25 December 2017

title

Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers (English)

1 reference

25 December 2017

1 reference

4

1 reference

25 December 2017

Christopher A Ross

13

object named as

Christopher A Ross

1 reference

25 December 2017

author name string

Marcus Kostka

1

1 reference

25 December 2017

Tobias Högen

2

1 reference

25 December 2017

Karin M Danzer

3

1 reference

25 December 2017

Matthias Habeck

5

1 reference

25 December 2017

Andreas Wirth

6

1 reference

25 December 2017

Richard Wagner

7

1 reference

25 December 2017

Charles G Glabe

8

1 reference

25 December 2017

Sabine Finger

9

1 reference

25 December 2017

Udo Heinzelmann

10

1 reference

25 December 2017

Patrick Garidel

11

1 reference

25 December 2017

Wenzhen Duan

12

1 reference

25 December 2017

Hans Kretzschmar

14

1 reference

25 December 2017

Armin Giese

15

1 reference

25 December 2017

language of work or name

English

0 references

publication date

7 February 2008

1 reference

25 December 2017

Journal of Biological Chemistry

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 December 2017

volume

283

1 reference

25 December 2017

issue

16

1 reference

25 December 2017

page(s)

10992-11003

1 reference

25 December 2017

Amyloid diseases: abnormal protein aggregation in neurodegeneration

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Nosology of Parkinson's disease: looking for the way out of a quagmire

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Alpha-synuclein and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

The aggregation and fibrillation of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Annular alpha-synuclein species from purified multiple system atrophy inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Occupational exposures to metals as risk factors for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

The relevance of iron in the pathogenesis of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Fluorescence-intensity distribution analysis and its application in biomolecular detection technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Vesicle-membrane fusion. Observation of simultaneous membrane incorporation and content release

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Single particle analysis of manganese-induced prion protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Effect of desferrioxamine, a strong iron (III) chelator, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M709634200

21 January 2018

Identifiers

DOI

10.1074/JBC.M709634200

1 reference

25 December 2017

PubMed ID

18258594

1 reference

25 December 2017